NIRV — Nirvana Life Sciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for Nirvana Life Sciences, fiscal year end - April 30th, CAD millions except per share, conversion factor applied.

	2021 October 31st	2022 April 30th	2023 April 30th	2024 April 30th	2025 April 30th
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	0.476	0.036	0.012	0.002	0.003
Net Total Receivables	0.009	0.014	0.017	0.019	0.017
Prepaid Expenses
Total Current Assets	0.532	0.144	0.069	0.021	0.019
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	—	0.343	0	—	—
Total Assets	0.532	0.487	0.069	0.021	0.019
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	0.549	0.648	1.01	1.16	1.51
Total Long Term Debt
Total Debt
Minority Interest
Total Liabilities	0.549	0.649	1	1.15	1.5
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	-0.016	-0.162	-0.936	-1.13	-1.48
Total Liabilities & Shareholders' Equity	0.532	0.487	0.069	0.021	0.019
Total Common Shares Outstanding